skip to Main Content

Cancer- Immune modulation and HBOT

Cancer- Immune modulation and HBOT

Hyperbaric Oxygen Therapy (HBOT) can indeed influence immune modulation in cancer therapy, offering potential benefits in the context of immunotherapy. Here are some key aspects of how HBOT can modulate the immune response in cancer treatment:

1. Enhancement of Immune Cell Function: HBOT can increase the function of various immune cells. By elevating oxygen levels in the blood and tissues, HBOT enhances the cytotoxic capabilities of immune cells such as macrophages and natural killer (NK) cells. This increased activity can improve the overall immune response against tumor cells.

2. Upregulation of Immune Genes: Research suggests that the combination of HBOT with immunotherapy may lead to the upregulation of immune genes, which play a crucial role in anti-tumor responses. This genetic modulation can enhance the effectiveness of immunotherapies by making the tumor environment more receptive to immune cell attack.

3. Conversion of Tumor Microenvironment: HBOT can alter the tumor microenvironment, potentially converting “cold” tumors (those not typically infiltrated by immune cells) into “hot” tumors (those that are infiltrated by immune cells). This transformation can increase the efficacy of immune checkpoint inhibitors and other forms of immunotherapy by making the tumors more visible and vulnerable to the immune system.

4. Reduction of Hypoxia: Tumor hypoxia is a significant barrier to effective immune response and immunotherapy. HBOT can reduce hypoxia within the tumor, diminishing the hypoxia-induced immunosuppressive factors and thereby facilitating a more robust immune attack on the tumor cells.

5. Synergistic Effects with Immunotherapy: Clinical studies have explored the synergistic effects of HBOT with immune checkpoint blockade therapies, particularly in cancers like triple-negative breast cancer (TNBC), where immunotherapy options are actively being expanded. HBOT may enhance the response rates to these therapies by improving immune cell infiltration and activity within the tumor.

In summary, HBOT can play a supportive role in cancer immunotherapy by modulating the immune system and altering the tumor microenvironment. This can potentially improve the outcomes of immunotherapy and contribute to a more comprehensive cancer treatment strategy.

Back To Top